# US 2024/0200128 A1 · Method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0200128 A1
- Document ID: US20240200128A1
- Status: Published application
- Kind: A1
- Application number: 18/352,701
- Filed: 2023-07-14
- Published: 2024-06-20
- Earliest claimed: 2016-09-29
- Assignees: Oxford Nanopore Technologies PLC
- Applicants: Oxford Nanopore Technologies PLC
- Inventors: Andrew John Heron; James Edward Graham; Richard Alexander Gutierrez; Rebecca Victoria Bowen; James White; Clive Gavin Brown; Daniel George Fordham
- Web page: https://patentgrep.com/patent/US20240200128A1

## CPC

- C12Q 1/6869: Methods for sequencing
- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- G01N 33/48721: {Investigating individual macromolecules, e.g. by translocation through nanopores (Coulter counters in general G01N15/12; fabrication methods for nanoscale apertures B81B1/00; sequencing of nucleic acids C12Q1/68)}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention provides a method of detecting a target polynucleotide in a sample comprising: (a) contacting the sample with a guide polynucleotide that binds to a sequence in the target polynucleotide and a polynucleotide-guided effector protein, wherein the guide polynucleotide and polynucleotide-guided effector protein form a complex with any target polynucleotide present in the sample; (b) contacting the sample with a membrane comprising a transmembrane pore: (c) applying a potential to the membrane; and (d) monitoring for the presence or absence of an effect resulting from the interaction of the complex with the transmembrane pore to determine the presence or absence of the complex, thereby detecting the target polynucleotide in the sample.

## Claims

### Claim at position 1

-68. (canceled)

### Claim 69

A kit comprising:
(a) a guide polynucleotide comprising (i) a nucleotide sequence that binds to a sequence in a target polynucleotide, (ii) a nucleotide sequence that binds to a polynucleotide guided effector protein, and (iii) an adaptor and/or an anchor, and
(b) a polynucleotide-guided effector protein.

### Claim 70 (depends on 69)

The kit according to claim 69 further comprising a polynucleotide binding protein, a microparticle, a membrane, and/or a transmembrane pore.

### Claim at position 4

-74. (canceled)

### Claim 75 (depends on 69)

The kit according to claim 69, wherein the guide polynucleotide is a guide RNA.

### Claim 76 (depends on 75)

The kit according to claim 75, wherein the guide RNA comprises a crRNA and a tracrRNA, wherein the anchor or the adaptor is present at the 5′ end of the tracrRNA, the 3′ end of the tracrRNA, or the 3′ end of the crRNA.

### Claim 77 (depends on 69)

The kit according to claim 69, wherein the anchor is a polypeptide anchor or a hydrophobic anchor.

### Claim 78 (depends on 77)

The kit according to claim 77, wherein the hydrophobic anchor is a lipid, fatty acid, sterol, carbon nanotube, cholesterol, palmitate, or tocopherol.

### Claim 79 (depends on 69)

The kit according to claim 69, wherein the adaptor comprises a barcode and/or a leader sequence.

### Claim 80 (depends on 69)

The kit according to claim 69, wherein the polynucleotide-guided effector protein is a RNA-guided effector protein.

### Claim 81 (depends on 80)

The kit according to claim 80, wherein the RNA-guided effector protein is a Cas, Cpf1 or C2c2 protein.

### Claim 82 (depends on 81)

The kit according to claim 81, wherein the Cas protein is a Cas9 protein.

### Claim 83

A kit comprising:
(a) a first guide polynucleotide comprising (i) a nucleotide sequence that binds to a first target sequence, (ii) a nucleotide sequence that binds to a polynucleotide guided effector protein, and (iii) an adaptor;
(b) a second guide polynucleotide comprising (i) a nucleotide sequence that binds to a second target sequence, (ii) a nucleotide sequence that binds to a polynucleotide guided effector protein, and (iii) an anchor; and
(c) a polynucleotide-guided effector protein.

### Claim 84 (depends on 83)

The kit according to claim 83, wherein the first target sequence and the second target sequence are nucleic acid sequences belonging to the same target polynucleotide.

### Claim 85 (depends on 83)

The kit according to claim 83, wherein the first target sequence and the second target sequence are nucleic acid sequences belonging to different target polynucleotides.

### Claim 86 (depends on 83)

A kit according to claim 83 further comprising a polynucleotide binding protein, a microparticle, a membrane, and/or a transmembrane pore.

### Claim 87 (depends on 83)

The kit according to claim 83, wherein the first guide polynucleotide and/or the second guide polynucleotide is a guide RNA.

### Claim 88 (depends on 87)

The kit according to claim 87, wherein the guide RNA comprises a crRNA and a tracrRNA, wherein the anchor or the adaptor is present at the 5′ end of the tracrRNA, the 3′ end of the tracrRNA, or the 3′ end of the crRNA.

### Claim 89 (depends on 83)

The kit according to claim 83, wherein the anchor is a polypeptide anchor or a hydrophobic anchor.

### Claim 90 (depends on 83)

The kit according to claim 83, wherein the adaptor comprises a barcode and/or a leader sequence.

### Claim 91 (depends on 83)

The kit according to claim 83, wherein the polynucleotide-guided effector protein is a RNA-guided effector protein.

### Claim 92 (depends on 91)

The kit according to claim 91, wherein the RNA-guided effector protein is a Cas, Cpf1 or C2c2 protein.
